Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11268)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 15, 2019 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang S, Orita H, Fukunaga T. Current surgical treatment of esophagogastric junction adenocarcinoma. World J Gastrointest Oncol 2019; 11(8): 567-578 [PMID: 31435459 DOI: 10.4251/wjgo.v11.i8.567] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i8/567.htm |
| Number | Citing Articles |
| 1 |
Peng Luo, Xiankai Chen, Yafan Yang, Ruixiang Zhang, Xiaozheng Kang, Jianjun Qin, Xiuzhu Qi, Yin Li. Lymph node metastases in middle and upper mediastinum of Siewert type II adenocarcinoma: A real‐world retrospective study. Cancer Medicine 2024; 13(4) doi: 10.1002/cam4.6919
|
| 2 |
Pierre Allemann, Pierre Fournier. Reflux Disease and Adenocarcinoma of the Esophagus and Cardia: Global Management and Surgical Treatment. Journal of Laparoendoscopic & Advanced Surgical Techniques 2020; 30(8): 869 doi: 10.1089/lap.2020.0079
|
| 3 |
Jinwen Shen, Xiu Zhu, Yian Du, Yuan Zhu, Pengfei Yu, Litao Yang, Zhiyuan Xu, Ling Huang, Yunli Zhang, Yanqiang Zhang, Luying Liu, Xiangdong Cheng. Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG). Trials 2021; 22(1) doi: 10.1186/s13063-021-05617-7
|
| 4 |
敏 袁. Advances in the Treatment of Esophagogastric Junction Cancer. Advances in Clinical Medicine 2024; 14(05): 2330 doi: 10.12677/acm.2024.1451690
|
| 5 |
Wen-Zhe Kang, Jin-Ming Shi, Bing-Zhi Wang, Jian-Ping Xiong, Xin-Xin Shao, Hai-Tao Hu, Jing Jin, Yan-Tao Tian. Adjuvant chemoradiotherapy <i>vs</i> adjuvant chemotherapy in locally advanced Siewert type II/III adenocarcinoma of gastroesophageal junction after D2/R0 resection. World Journal of Gastrointestinal Oncology 2022; 14(8): 1540-1551 doi: 10.4251/wjgo.v14.i8.1540
Abstract(461) |
Core Tip(447) |
Full Article(HTML)(1439)
|
Full Article (PDF)-1495K(126)
|
Full Article (Word)-905K(51)
|
Audio-360K(6)
|
Peer-Review Report-228K(57)
|
Answering Reviewers-87K(56)
|
Times Cited (0)
|
Total Visits (6575)
|
Open
|
| 6 |
Jens Osterkamp, Rune Strandby, Nikolaj Nerup, Morten-Bo Svendsen, Lars-Bo Svendsen, Michael Achiam. Intraoperative near-infrared lymphography with indocyanine green may aid lymph node dissection during robot-assisted resection of gastroesophageal junction cancer. Surgical Endoscopy 2023; 37(3): 1985 doi: 10.1007/s00464-022-09684-y
|
| 7 |
Gerd Jomrich, Dagmar Kollmann, Lavinia Wilfing, Sanja Radosavljevic, Dariga Ramazanova, Robin Ristl, Richard P. Grose, Aysegül Ilhan-Mutlu, Matthias Preusser, Christina Fassnacht, Yi-Chien Tsai, Emmanuella Guenova, Sebastian F. Schoppmann. Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy. European Surgery 2021; 53(6): 287 doi: 10.1007/s10353-021-00700-4
|
| 8 |
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim, Si Young Song. Gastrointestinal Cancer. 2023; : 113 doi: 10.1007/978-981-99-0815-8_16
|
| 9 |
Hao Wu, Liang Shang, Fengying Du, Mengdi Fu, Jin Liu, Zhen Fang, Leping Li. Transhiatal versus transthoracic surgical approach for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction: a meta-analysis. Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1107 doi: 10.1080/17474124.2020.1806710
|
| 10 |
Pengfei Lu, Min Xia, Juan Li, Hongzhi Qi, Hui Wang, Rui Mao. XRCC1 is linked to poor prognosis in adenocarcinoma of the esophagogastric junction after radiotherapy: transcriptome and alternative splicing events analysis. Clinical and Translational Oncology 2024; doi: 10.1007/s12094-024-03773-1
|
| 11 |
Sabah Noori Abdulraheem, Talib A. Majeed, Noufel sh. Alshadood, Saleh Abdulkareem Saleh, Aqeel Shakir Mahmood. MCQs in General Surgical Oncology. 2024; : 3 doi: 10.1007/978-3-031-65738-2_1
|
| 12 |
Li Yuan, Shao-Wei Mo, Zhi-Yuan Xu, Hang Lv, Jing-Li Xu, Kai-Bo Guo, Can Hu, Xiao-Feng Wang, Gui-Ping Chen, Jiang-Jiang Qin, Xiang-Dong Cheng. p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier. Pharmacological Research 2021; 165: 105411 doi: 10.1016/j.phrs.2020.105411
|
| 13 |
Jens Thomas Fredrik Osterkamp, Nikolaj Nerup, Morten Bo S Svendsen, Rune B Strandby, Lars Bo Svendsen, Eske K Aasvang, Henrik Vad, Astrid Plamboeck, Michael P Achiam. Central ligation or partial preservation of the right gastric artery does not seem to affect conduit or anastomotic perfusion during robot-assisted resection of gastroesophageal junction cancer: a randomized clinical trial. Diseases of the Esophagus 2024; doi: 10.1093/dote/doae102
|
| 14 |
Qiying Song, Xiongguang Li, Di Wu, Shuo Li, Tianyu Xie, Yixun Lu, Liyu Zhang, Ziyao Xu, Lu Liu, Xin Guo, Xinxin Wang. The abdominal-transhiatal surgical approach versus the thoracoabdominal surgical approach in Siewert type II adenocarcinoma of the esophagogastric junction: protocol for a multicenter prospective, open, parallel, and randomized controlled trial. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09375-w
|
| 15 |
Jia-Bin Huang, Bin-Bin Hu, Rong He, Lian He, Chen Zou, Chang-Feng Man, Yu Fan. Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction. Frontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.787800
|
| 16 |
Yangyang Wang, Shuchang Wang, Chunchao Zhu, Hui Cao, Zizhen Zhang, Enhao Zhao. <p>The Association Between Immune Characteristic and Clinical Pathology in Chinese Patients with Adenocarcinoma of Esophagogastric Junction</p>. Cancer Management and Research 2020; : 3259 doi: 10.2147/CMAR.S235722
|
| 17 |
Rodica Bîrlă, Petre Hoara, Florin Achim, Valeriu Dinca, Diana Ciuc, Silviu Constantinoiu, Adrian Constantin. Minimally invasive surgery for gastro-oesophageal junction adenocarcinoma: Current evidence and future perspectives. World Journal of Gastrointestinal Oncology 2023; 15(10): 1675-1690 doi: 10.4251/wjgo.v15.i10.1675
Abstract(389) |
Core Tip(420) |
Full Article(HTML)(1376)
|
Full Article with Cover (PDF)-713K(74)
|
Full Article (Word)-150K(34)
|
Audio-640K(3)
|
Peer-Review Report-226K(45)
|
Answering Reviewers-159K(46)
|
Full Article (PDF)-512K(137)
|
Full Article (XML)-274K(46)
|
Times Cited (0)
|
Total Visits (3893)
|
Open
|